C.H. Robinson: Strong Earnings, But Market Fixates on the Verdict

The freight broker hit mid-cycle margins in a trough, yet a jumbo jury verdict and rising insurance costs are driving the stock sharply lower.

CHRW · Earnings Call · 2026-07-29

The Earnings Beat Was Real

C.H. Robinson's second quarter was a genuine standout in a freight market that is still in the dumps. The Cass Freight Shipment Index fell another 3.3% year-over-year Cass Freight Shipment Index - the 15th straight quarterly decline - yet the company grew total revenue 19.3%, grew adjusted gross profit (AGP) 6.5%, and expanded adjusted operating income 20%. Management had promised "higher highs and higher lows" across the freight cycle, and they delivered: both NAST and Global Forwarding hit their mid-cycle operating margin targets despite the depressed demand. As CFO Damon Lee noted in the prepared remarks, "In Q2, this manifested itself in a 96% incremental operating margin with 96% of our year-over-year increase in AGP falling to our adjusted operating income." “In Q2, this manifested itself in a 96% incremental operating margin with 96% of our year-over-year increase in AGP falling to our adjusted operating income.” — Damon Lee · 2026-07-29 That performance is attributable to the Lean AI strategy and disciplined revenue management capability. President of NAST, Michael Castagnetto, highlighted that productivity improvements are compounding: "we continue to deliver double-digit increases in NAST shipments per person per day with a 15% year-over-year increase in Q2." “we continue to deliver double-digit increases in NAST shipments per person per day with a 15% year-over-year increase in Q2.” — Michael Castagnetto · 2026-07-29 Even more striking is the company's ability to hold truckload profit per load flat despite a 29% spike in linehaul cost per mile, a feat management credits to their refined pricing and cost-discovery tools.

But the Verdict Looms

The market, however, is oddly unimpressed. CHRW shares have fallen 13.4% over the past 90 trading days and are down 32.4% from the July 21 peak of $209.42, even though the earnings report landed near that peak. Why the disconnect? The answer is the company's newly emerged legal risk: a Texas jury issued an advisory verdict against the company in a trucking negligence case, with damages likely exceeding $200 million. Management strongly disagrees with the verdict. In the Q&A, CEO David Bozeman was emphatic: "First of all, we really believe this case was decided based on emotion rather than the law." “First of all, we really believe this case was decided based on emotion rather than the law.” — David Bozeman · 2026-07-29 He also positioned it as an industry-wide problem: "Nuclear verdicts such as this, are a transportation issue overall." “Nuclear verdicts such as this, are a transportation issue overall.” — David Bozeman · 2026-07-29 The company plans to appeal if the verdict becomes final, but the process could take years. CFO Damon Lee acknowledged the financial overhang: "we know insurance is going to inflate year-over-year" and that coverage is only contracted through 2026. “we know insurance is going to inflate year-over-year” — Damon Lee · 2026-07-29 He added that the verdict would not change their capital allocation strategy or M&A appetite, but the market is clearly pricing in a multi-year legal and insurance drag. This represents a sharp shift from even three months ago, when management were confident about the Supreme Court case. In the April call, Bozeman had said: "The Montgomery case is a case that we expect to win." “The Montgomery case is a case that we expect to win.” — David P. Bozeman, President and Chief Executive Officer · 2026-04-29 That case is now resolved (in the industry's favor), but this new state-court verdict is a fresh, idiosyncratic risk.

And so again, it will affect the industry. It will affect us. We'll solve that problem like we solve many other problems… We feel like, again, our insurance coverage today is more like an asset provider than it is a broker.
Damon Lee · 2026-07-29

The Market Is Pricing In Risk

The fundamental picture is actually quite solid. Operating margin, while still low at 4.4%, is up from cycle troughs, and management has raised its 2026 operating income target to the low end of $964M-$1.04B even with a market contraction of 3%. Operating margin has trended up steadily since 2023, but remains relatively thin. The company also generated $301M of cash returned to shareholders in the quarter, including $226M of buybacks. However, free cash flow turned sharply negative in Q1 (and remained weak in Q2) due to the spike in freight rates inflating receivables. Free cash flow margin swung from +7% in Q4 2025 to +0.9% in Q2 2026 as the surging spot rates blew up net operating working capital. Net debt also increased to -1.64x EBITDA, but still investment grade. The market's skepticism may be overdone, but the legal tail risk is hard to quantify. The company argues that the responsible carrier is independent, and that they will prevail on appeal. Yet, as Bozeman conceded, "there's judicial discretion on the timing of post-trial motions" and the appeal process could stretch for years. “there's judicial discretion on the timing of post-trial motions” — David Bozeman · 2026-07-29 In the meantime, insurance costs will rise for the entire industry, and CHRW's scale and financial strength may actually become a competitive advantage as smaller brokers exit.

What Matters Going Forward

For now, the market is treating the verdict as a potential existential threat, but management's track record suggests they can navigate it. The company has consistently proven that its earnings growth is secular, driven by productivity gains that remain in "early innings." The key question is whether the legal overhang will cap the multiple or attract buyers on dips. The stock's 32% drawdown from its peak may already be pricing in a worst-case outcome, but the uncertainty around the final judgment and insurance costs will keep many investors on the sidelines. As the company itself noted, "we're not immune to an increase in spot rates," but they have proven adept at managing even the sharpest inflections. “As we've said consistently, we're not immune to an increase in spot rates. But our revenue management disciplines and our improved price and cost discovery enable us to manage through spot rate inflections better than we ever have in the past.” — David Bozeman · 2026-07-29 If the appeal succeeds, CHRW could re-rate quickly; if not, the stock may remain in a penalty box. Either way, this is a name-in-motion worth watching closely.